INHX nice strong move coming out of the inverted head and shoulder pattern. I expect this to be a big mover.
INHX Chart
Inhibitex Inc.
9005 Westside Parkway
Alpharetta, GA 30004
United States - Map
Phone: 678-746-1100
Web Site:
Inhibitex is a clinical stage infections disease biopharmaceutical company.
DETAILS
Index Membership: N/A
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 34
BUSINESS SUMMARY
Inhibitex, Inc., a biopharmaceutical company, develops differentiated anti-infective products to prevent and treat serious infections primarily shingles and chronic hepatitis C. Its anti- infective product candidates include FV-100, an orally available nucleoside analogue prodrug, which completed Phase I trials used for the treatment of herpes zoster or shingles; and aurexis, a humanized monoclonal antibody, which completed Phase IIa trials used for the treatment of serious S. aureus infections. The company’s preclinical product candidates include HCV polymerase inhibitors, which are used for the treatment of chronic HCV infection; HIV integrase inhibitors that are used for the treatment of HIV infection; and staphylococcal vaccines, an active vaccine to prevent S. aureus infections. It has MSCRAMM based license and collaboration agreement with Wyeth Pharmaceuticals for the development of staphylococcal vaccines; and royalty-bearing license agreement with Cardiff University and Katholieke Universiteit for intellectual property of HCV nucleoside polymerase inhibitors. Inhibitex, Inc. was founded in 1994 and is based in Alpharetta, Georgia.
INHX Inhibitex Inc.
Linear Mode
